International Stroke Conference; Feb. 4-6, 2026; New Orleans. A prior history of ischemic stroke may signal higher risk for another stroke during pregnancy and in the early postpartum period, ...
A 26% relative hazard reduction in recurrent ischemic stroke was observed (HR 0.74), with primary efficacy assessed as time to first ischemic stroke. OCEANIC-STROKE trial data show asundexian cuts ...
AIM: The “2026 Guideline for the Early Management of Patients With AIS” replaces the “2018 Guidelines for the Early Management of Patients With AIS” and the 2019 update to reflect recent advances in ...
The National Institutes of Health (NIH) on Tuesday discontinued the low-dose rivaroxaban arm of its ongoing Phase 3 CAPTIVA ...
This “long overdue” update expands the pools of patients eligible for thrombolysis and thrombectomy, and tackles pediatric ...
For patients with non-large vessel occlusion, acute ischemic stroke and salvageable brain tissue, intravenous tenecteplase ...
A neuroprotective agent improved 90-day functional outcomes and reduced poststroke depression and anxiety in patients with ischemic stroke.
The World Health Organization in 2023 advised against using nonsugar sweeteners for weight control due to a lack of long-term ...
The rationale behind the treatment is that, because genetic FXI deficiency has been linked with reduced risk of ischemic ...
News-Medical.Net on MSN
Ischemic stroke increases expectant mother's risk for another stroke during or soon after pregnancy
Having had a stroke caused by blocked blood vessels (ischemic stroke) more than doubled an expectant mother's odds of having ...
The results showed that women who followed the Mediterranean diet most closely had significantly lower stroke risk across the ...
Intravenous tenecteplase may improve functional outcomes for patients with salvageable brain tissue under certain stroke circumstances.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results